Carboplatin and programmed death‐ligand 1 blockade synergistically produce a similar antitumor effect to carboplatin alone in murine ID8 ovarian cancer model

By  

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol. 44, Iss. 2, 2018-02 ,pp. : 303-311

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical significance of programmed cell death‐ligand 1 expression and the immune microenvironment at the invasive front of colorectal cancers with high microsatellite instability

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 4, 2018-02 ,pp. : 822-832

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expression of Programmed Death 1 Ligand in Different Compartments of Chronic Lymphocytic Leukemia

By  

Acta Haematologica, Vol. 134, Iss. 4, 2015-0 ,pp. : 255-262

Karger

Access to resources Recommend Favorite

Tumour‐infiltrating lymphocytes and expression of programmed death ligand 1 (PD‐L1) in melanoma brain metastases

By  

HISTOPATHOLOGY, Vol. 66, Iss. 2, 2015-01 ,pp. : 289-299

John Wiley & Sons Inc

Access to resources Recommend Favorite

Programmed death ligand 1 is over‐expressed by neutrophils in the blood of patients with active tuberculosis

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 41, Iss. 7, 2011-07 ,pp. : 1941-1947

John Wiley & Sons Inc

Access to resources Recommend Favorite